- Home
- AAPG vs BL Comparison
AAPG vs BL Comparison
Compare AAPG & BL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAPG
- BL
- Stock Information
- Founded
- AAPG 2009
- BL 2001
- Country
- AAPG China
- BL United States
- Employees
- AAPG N/A
- BL N/A
- Industry
- AAPG Biotechnology: Pharmaceutical Preparations
- BL Computer Software: Prepackaged Software
- Sector
- AAPG Health Care
- BL Technology
- Exchange
- AAPG Nasdaq
- BL Nasdaq
- Market Cap
- AAPG 3.6B
- BL 3.1B
- IPO Year
- AAPG 2025
- BL 2016
- Fundamental
- Price
- AAPG $40.54
- BL $54.29
- Analyst Decision
- AAPG Buy
- BL Hold
- Analyst Count
- AAPG 1
- BL 12
- Target Price
- AAPG N/A
- BL $58.50
- AVG Volume (30 Days)
- AAPG 11.7K
- BL 798.8K
- Earning Date
- AAPG 11-06-2025
- BL 11-06-2025
- Dividend Yield
- AAPG N/A
- BL N/A
- EPS Growth
- AAPG N/A
- BL 48.84
- EPS
- AAPG N/A
- BL 1.34
- Revenue
- AAPG $54,524,554.00
- BL $674,325,000.00
- Revenue This Year
- AAPG N/A
- BL $10.45
- Revenue Next Year
- AAPG $387.72
- BL $8.77
- P/E Ratio
- AAPG N/A
- BL $41.10
- Revenue Growth
- AAPG N/A
- BL 8.00
- 52 Week Low
- AAPG $16.50
- BL $40.82
- 52 Week High
- AAPG $48.45
- BL $66.25
- Technical
- Relative Strength Index (RSI)
- AAPG N/A
- BL 53.42
- Support Level
- AAPG N/A
- BL $53.62
- Resistance Level
- AAPG N/A
- BL $55.75
- Average True Range (ATR)
- AAPG 0.00
- BL 1.40
- MACD
- AAPG 0.00
- BL 0.21
- Stochastic Oscillator
- AAPG 0.00
- BL 66.82
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.
About BL BlackLine Inc.
BlackLine Inc is engaged in providing financial accounting close solutions delivered as Software as a Service (SaaS). The Company's solutions enable its customers to address various aspects of their critical processes, including financial close & consolidation, intercompany accounting, and invoice-to-cash. The majority of the revenue of the company is earned in the United States.